Zyrtec OTC Launch Does Not Deliver Knockout To Rx Remedies – Report
This article was originally published in The Tan Sheet
Executive Summary
Fewer consumers than expected have switched from Rx products to OTC Zyrtec in part because managed care organizations are not discouraging use of prescription allergy medications, according to research by Nielsen and Wolters Kluwer Health
You may also be interested in...
Prepaid Cards Could Help OTC Switches Gain Against Rx Competitors
Medagate Corp.’s payment technology that simplifies insurance reimbursement for OTCs could help level the playing field with competing prescription products.
Prepaid Cards Could Help OTC Switches Gain Against Rx Competitors
Medagate Corp.’s payment technology that simplifies insurance reimbursement for OTCs could help level the playing field with competing prescription products.
Prepaid Cards Could Help OTC Switches Gain Against Rx Competitors
Medagate Corp.’s payment technology that simplifies insurance reimbursement for OTCs could help level the playing field with competing prescription products.